A comprehensive review of SARS-CoV-2 vaccines: Pfizer, moderna & Johnson & Johnson

R Patel, M Kaki, VS Potluri, P Kahar… - Human vaccines & …, 2022 - Taylor & Francis
The novel coronavirus outbreak was declared a pandemic in March 2020. We are reviewing
the COVID-19 vaccines authorized for use in the United States by discussing the …

A summary of the SARS-CoV-2 vaccines and technologies available or under development

ZA Abdulla, SM Al-Bashir, NS Al-Salih, AA Aldamen… - Pathogens, 2021 - mdpi.com
Since the beginning of 2020, the world has been in a race to develop vaccines that can
control the COVID-19 pandemic. More than 250 projects have been initiated for this …

[HTML][HTML] Review of COVID-19 vaccines approved in the United States of America for emergency use

D Vasireddy, P Atluri, SV Malayala… - Journal of clinical …, 2021 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus
causing a global pandemic. Coronaviruses are a large family of single-stranded ribonucleic …

Efficacy of COVID-19 vaccines: From clinical trials to real life

D Deplanque, O Launay - Therapies, 2021 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread around
the globe leading to the COVID-19 pandemic. To mitigate the effects of the virus on public …

An updated review of SARS-CoV-2 vaccines and the importance of effective vaccination programs in pandemic times

C García-Montero, O Fraile-Martínez, C Bravo… - Vaccines, 2021 - mdpi.com
Since the worldwide COVID-19 pandemic was declared a year ago, the search for vaccines
has become the top priority in order to restore normalcy after 2.5 million deaths worldwide …

SARS-CoV-2: Targeted managements and vaccine development

M Bakhiet, S Taurin - Cytokine & growth factor reviews, 2021 - Elsevier
Infection with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) results in
diverse outcomes. The symptoms appear to be more severe in males older than 65 and …

[HTML][HTML] Targets and strategies for vaccine development against SARS-CoV-2

JA Malik, AH Mulla, T Farooqi, FH Pottoo… - Biomedicine & …, 2021 - Elsevier
Abstract The SARS-CoV-2, previously called a novel coronavirus, that broke out in the
Wuhan city of China caused a significant number of morbidity and mortality in the world. It is …

The 2020 pandemic: current SARS-CoV-2 vaccine development

SO Alturki, SO Alturki, J Connors, G Cusimano… - Frontiers in …, 2020 - frontiersin.org
Coronaviruses are enveloped viruses with a positive-sense single-stranded RNA genome
infecting animals and humans. Coronaviruses have been described more than 70 years ago …

COVID-19 vaccines: concerns beyond protective efficacy and safety

CC Lai, IT Chen, CM Chao, PI Lee, WC Ko… - Expert review of …, 2021 - Taylor & Francis
Introduction Several vaccine candidates have been developed using different platforms,
including nucleic acids (DNA and RNA), viral vectors (replicating and non-replicating), virus …

COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies

K Rawat, P Kumari, L Saha - European journal of pharmacology, 2021 - Elsevier
Coronavirus Disease 2019 named as COVID-19 imposing a huge burden on public health
as well as global economies, is caused by a new strain of betacoronavirus named as SARS …